logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yasuto Takeuchi

Okayama University Hospital
H指数:20
被引数:1,209

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab

durvalumab联合tremelimumab治疗肝细胞癌患者淋巴细胞计数早期变化可预测临床结局

Journal of Gastroenterology and Hepatology
IF3.4
2026-10-070
OAAI
Yuichi Honma; Shigeo Shimose; Takanori Ito; Issei Saeki; Joji Tani; Takanori Matsuura; Tetsu Tomonari; Yasuto Takeuchi; Nobuhito Taniki; Kyo Sasaki; Ryu Sasaki; Takeshi Hatanaka; Satoru Kakizaki; Naoki Yoshioka; Takehito Naito; Mamiko Takeuchi; Tetsuya Yasunaka; Masahiro Sakata; Hideki Iwamoto; Tomotake Shirono; Satoshi Itano; Norikazu Tanabe; Takafumi Yamamoto; Atsushi Naganuma; Yuki Kanayama; Hisamitsu Miyaaki; Sohji Nishina; Nobuhiro Nakamoto; Motoyuki Otsuka; Tetsuji Takayama; Yuzo Kodama; Hideki Kobara; Taro Takami; Hiroki Kawashima; Takumi Kawaguchi; Masaru Harada
Clinical and pathological significance of serum anti-PD-1 autoantibodies in acute-onset and chronic autoimmune hepatitis

血清抗PD-1自身抗体在急性发作和慢性自身免疫性肝炎中的临床及病理学意义

Hepatology International
IF6.1
2026-09-290
OAAI
Takashi Oda; Akinobu Takaki; Kenichi Harada; Teruko Arinaga-Hino; Masanori Abe; Takeshi Matsui; Atsushi Takahashi; Hiromasa Ohira; Yoshiyuki Suzuki; Nobuhiro Nakamoto; Atsushi Tanaka; Kazuyuki Matsumoto; Jinpeng Li; Nozomi Miyake; Masahiko Sue; Takuya Adachi; Yasuto Takeuchi; Hideki Onishi; Miwa Kawanaka; Motoyuki Otsuka
Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026

代谢功能障碍相关脂肪性肝病（MASLD）2026年循证临床实践指南

Journal of Gastroenterology
IF5.5
2026-05-130
OAAI
Norio Akuta; Tomomi Kogiso; Kenichi Ikejima; Motoyuki Otsuka; Takumi Kawaguchi; Miwa Kawanaka; Hirokazu Takahashi; Nobuharu Tamaki; Hayato Nakagawa; Hayato Hikita; Hideki Fujii; Kanji Yamaguchi; Masato Yoneda; Kazuyoshi Kon; Akira Uchiyama; Yuya Seko; Sadatsugu Sakane; Ryuta Shigefuku; Naoto Fujiwara; Michihiro Iwaki; Takashi Kobayashi; Takuya Adachi; Yasuto Takeuchi; Tsubasa Tsutsumi; Dan Nakano; Kaoru Shibayama; Noriyo Urata; Hisamitsu Miyaaki; Hidekatsu Kuroda; Masahiro Koseki; Hirohito Sone; Yasuhiro Matsubayashi; Keisuke Kakisaka; Atsushi Takai; Kazuo Notsumata; Masataka Seike; Yoshiyuki Takei; Yoshifumi Takeyama; Susumu Eguchi; Sumio Watanabe; Hajime Isomoto; Hiroshi Yotsuyanagi; Takao Itoi; Tetsuo Takehara; Satoshi Mochida
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026

代谢功能障碍相关脂肪性肝病（MASLD）2026年循证临床实践指南

Hepatology Research
IF3.4
2026-05-120
OAAI
Norio Akuta; Tomomi Kogiso; Kenichi Ikejima; Motoyuki Otsuka; Takumi Kawaguchi; Miwa Kawanaka; Hirokazu Takahashi; Nobuharu Tamaki; Hayato Nakagawa; Hayato Hikita; Hideki Fujii; Kanji Yamaguchi; Masato Yoneda; Kazuyoshi Kon; Akira Uchiyama; Yuya Seko; Sadatsugu Sakane; Ryuta Shigefuku; Naoto Fujiwara; Michihiro Iwaki; Takashi Kobayashi; Takuya Adachi; Yasuto Takeuchi; Tsubasa Tsutsumi; Dan Nakano; Kaoru Shibayama; Noriyo Urata; Hisamitsu Miyaaki; Hidekatsu Kuroda; Masahiro Koseki; Hirohito Sone; Yasuhiro Matsubayashi; Keisuke Kakisaka; Atsushi Takai; Kazuo Notsumata; Masataka Seike; Yoshiyuki Takei; Yoshifumi Takeyama; Susumu Eguchi; Sumio Watanabe; Hajime Isomoto; Hiroshi Yotsuyanagi; Takao Itoi; Tetsuo Takehara; Satoshi Mochida
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B

阿特珠单抗联合贝伐珠单抗在Child-Pugh B级肝细胞癌患者中的有效性与安全性

LIVER INTERNATIONAL
IF5.2
2025-11-280
OAAI
Sasaki, Ryu; Shimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Miuma, Satoshi; Shirono, Tomotake; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Kanayama, Yuki; Naganuma, Atsushi; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Miyaaki, Hisamitsu
Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗后序贯免疫检查点抑制剂再治疗的结局

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
IF3.4
2025-11-010
OAAI
Ito, Takanori; Shimose, Shigeo; Saeki, Issei; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Miyaaki, Hisamitsu; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Takami, Taro; Kawaguchi, Takumi; Kawashima, Hiroki
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study

代谢相关脂肪性肝病与度伐利尤单抗和特瑞普利单抗在晚期肝细胞癌患者临床结局中的关联：一项多中心研究

Hepatology Research
IF3.4
2025-08-210
PRE
Takeshi Hatanaka; Shigeo Shimose; Takanori Ito; Joji Tani; Tetsu Tomonari; Issei Saeki; Yasuto Takeuchi; Kyo Sasaki; Yuichi Honma; Ryu Sasaki; Naoki Yoshioka; Takehito Naito; Mamiko Takeuchi; Tetsuya Yasunaka; Masahiro Sakata; Hideki Iwamoto; Satoshi Itano; Yuki Kanayama; Tomotake Shirono; Norikazu Tanabe; Takafumi Yamamoto; Atsushi Naganuma; Sohji Nishina; Motoyuki Otsuka; Hideki Kobara; Taro Takami; Tetsuji Takayama; Takumi Kawaguchi; Hiroki Kawashima; Masaru Harada; Hisamitsu Miyaaki; Satoru Kakizaki; Hepatology InVestigator Experts in Japan (HIVE-J) Study Group
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
HEPATOLOGY INTERNATIONAL
IF6.1
2025-02-280
PRE
Shimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Hepatology InVestigator Experts Japan HIVE-J Study Grp
Antitumor effects and immune-mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma

durvalumab联合tremelimumab治疗不可切除的肝细胞癌的抗肿瘤作用和免疫介导的不良事件

HEPATOLOGY RESEARCH
IF3.4
2024-12-150
OA
Ito, Takanori; Shimose, Shigeo; Tani, Joji; Tomonari, Tetsu; Saeki, Issei; Takeuchi, Yasuto; Hatanaka, Takeshi; Sasaki, Kyo; Kakizaki, Satoru; Kanayama, Yuki; Yoshioka, Naoki; Naito, Takehito; Takeuchi, Mamiko; Yasunaka, Tetsuya; Sakata, Masahiro; Iwamoto, Hideki; Itano, Satoshi; Shirono, Tomotake; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Nishina, Sohji; Otsuka, Motoyuki; Takami, Taro; Takayama, Tetsuji; Kawaguchi, Takumi; Kawashima, Hiroki
Response to the letter: Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab

对字母的回应: 使用阿特珠单抗联合贝伐单抗在HCC中过渡到转换治疗的预测因素

LIVER INTERNATIONAL
IF5.2
2024-05-080
PRE
Kikuchi, Tatsuya; Takeuchi, Yasuto; Nouso, Kazuhiro; Kariyama, Kazuya; Kuwaki, Kenji; Toshimori, Junichi; Iwado, Shota; Moriya, Akio; Hagihara, Hiroaki; Takabatake, Hiroyuki; Tada, Toshifumi; Yasunaka, Tetsuya; Sakata, Masahiro; Sue, Masahiko; Miyake, Nozomi; Adachi, Takuya; Wada, Nozomu; Onishi, Hideki; Shiraha, Hidenori; Takaki, Akinobu; Otsuka, Motoyuki
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab

使用阿特珠单抗联合贝伐单抗治疗肝细胞癌向转化治疗过渡的预测因素

LIVER INTERNATIONAL
IF5.2
2024-03-156
OAAI
Kikuchi, Tatsuya; Takeuchi, Yasuto; Nouso, Kazuhiro; Kariyama, Kazuya; Kuwaki, Kenji; Toshimori, Junichi; Iwado, Shota; Moriya, Akio; Hagihara, Hiroaki; Takabatake, Hiroyuki; Tada, Toshifumi; Yasunaka, Tetsuya; Sakata, Masahiro; Sue, Masahiko; Miyake, Nozomi; Adachi, Takuya; Wada, Nozomu; Onishi, Hideki; Shiraha, Hidenori; Takaki, Akinobu; Otsuka, Motoyuki
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
JOURNAL OF CLINICAL INVESTIGATION
IF13.6
2023-11-156
OAAI
Li, Mengjiao; Nishimura, Tatsunori; Takeuchi, Yasuto; Hongu, Tsunaki; Wang, Yuming; Shiokawa, Daisuke; Wang, Kang; Hirose, Haruka; Sasahara, Asako; Yano, Masao; Ishikawa, Satoko; Inokuchi, Masafumi; Ota, Tetsuo; Tanabe, Masahiko; Tada, Kei-ichiro; Akiyama, Tetsu; Cheng, Xi; Liu, Chia-Chi; Yamashita, Toshinari; Sugano, Sumio; Uchida, Yutaro; Chiba, Tomoki; Asahara, Hiroshi; Nakagawa, Masahiro; Sato, Shinya; Miyagi, Yohei; Shimamura, Teppei; Nagai, Luis Augusto E.; Kanai, Akinori; Katoh, Manami; Nomura, Seitaro; Nakato, Ryuichiro; Suzuki, Yutaka; Tojo, Arinobu; Voon, Dominic C.; Ogawa, Seishi; Okamoto, Koji; Foukakis, Theodoros; Gotoh, Noriko
The membrane-linked adaptor FRS2β fashions a cytokine-rich inflammatory microenvironment that promotes breast cancer carcinogenesis
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
IF9.1
2021-10-184
OAAI
Takeuchi, Yasuto; Kimura, Natsuko; Murayama, Takahiko; Machida, Yukino; Iejima, Daisuke; Nishimura, Tatsunori; Terashima, Minoru; Wang, Yuming; Li, Mengjiao; Sakamoto, Reiko; Yamamoto, Mizuki; Itano, Naoki; Inoue, Yusuke; Ito, Masataka; Yoshida, Nobuaki; Inoue, Jun-ichiro; Akashi, Koichi; Saya, Hideyuki; Fujita, Koji; Kuroda, Masahiko; Kitabayashi, Issay; Voon, Dominic; Suzuki, Takeshi; Tojo, Arinobu; Gotoh, Noriko
Abnormal fucosylation of alpha-fetoprotein in patients with nonalcoholic steatohepatitis
HEPATOLOGY RESEARCH
IF3.4
2021-03-193
PREAI
Nouso, Kazuhiro; Furubayashi, Yoshie; Kariyama, Kazuya; Wakuta, Akiko; Miyake, Nozomi; Inoue, Kanae; Nagai, Yuta; Murakami, Shiho; Adachi, Takuya; Oyama, Atsushi; Wada, Nozomu; Takeuchi, Yasuto; Sakata, Masahiro; Yasunaka, Tetsuya; Onishi, Hideki; Shiraha, Hidenori; Takaki, Akinobu; Shiota, Shohei; Yasuda, Satoshi; Toyoda, Hidenori; Kawanaka, Miwa; Kumada, Takashi; Okada, Hiroyuki

研究方向

暂未获取到该数据
A
Akinobu Takaki
H 指数:40论文数:210被引数:5,900
H
Hideki Onishi
H 指数:27论文数:245被引数:3,058
H
Hidenori Shiraha
H 指数:33论文数:184被引数:3,685
K
Kazuhiro Nouso
H 指数:51论文数:418被引数:9,236
K
Kenji Kuwaki
H 指数:30论文数:216被引数:3,991
F
Fusao Ikeda
H 指数:35论文数:270被引数:4,935
N
Nozomu Wada
H 指数:16论文数:71被引数:778
S
Shinichiro Nakamura
H 指数:41论文数:396被引数:5,982
K
Kazuhide Yamamoto
H 指数:56论文数:760被引数:1.2万
T
Tetsuya Yasunaka
H 指数:23论文数:161被引数:1,549